Since its inception in 2018, American Oncology Network, Inc. (Nasdaq: AONC) has offered an innovative model of physician-led, community-based oncology management. AONC preserves and elevates community oncology by helping its physicians navigate the complex healthcare landscape, providing them an efficient platform to work autonomously and thrive, and most importantly, improving the quality of patient care that is being delivered. The network is an alliance of physicians and veteran healthcare leaders partnering to ensure the long-term success and viability of oncology diagnosis and treatment in community-based settings. As of September 30, 2023, AONC has more than 200 providers across 85 locations in 19 states and the District of Columbia. AONC’s robust platform provides oncology practices with comprehensive support, access to revenue- diversifying adjacent services and practice management expertise to empower physicians to make cancer care better for every patient.
Company profile
Ticker
AONC
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Digital Transformation Opportunities Corp.
SEC CIK
AONC stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
22 Apr 24
8-K
Regulation FD Disclosure
1 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
American Oncology Network, Inc. (“AON”) Announces Fourth Quarter and Full Year 2023 Financial Results
28 Mar 24
424B5
Prospectus supplement for primary offering
7 Dec 23
EFFECT
Notice of effectiveness
7 Dec 23
CORRESP
Correspondence with SEC
4 Dec 23
S-8
Registration of securities for employees
27 Nov 23
8-K
Index to Financial Statements
27 Nov 23
S-1/A
IPO registration (amended)
17 Nov 23
Latest ownership filings
4
Stephen Divers
22 Mar 24
4
Stephen Divers
20 Mar 24
4/A
Stephen Divers
22 Jan 24
3/A
Stephen Divers
22 Jan 24
4
Stephen Divers
8 Jan 24
4/A
Stephen Divers
8 Jan 24
4
Change in insider ownership
5 Jan 24
SC 13D
HealthQuest Tactical Opportunities Fund, L.P.
9 Nov 23
3
Garheng Kong
9 Nov 23
SC 13D/A
AEA GROWTH EQUITY FUND LP
13 Oct 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 51.65 mm | 51.65 mm | 51.65 mm | 51.65 mm | 51.65 mm | 51.65 mm |
Cash burn (monthly) | 7.02 mm | (no burn) | 8.13 mm | 2.81 mm | 1.30 mm | 1.21 mm |
Cash used (since last report) | 48.19 mm | n/a | 55.83 mm | 19.26 mm | 8.90 mm | 8.34 mm |
Cash remaining | 3.46 mm | n/a | -4.17 mm | 32.39 mm | 42.75 mm | 43.31 mm |
Runway (months of cash) | 0.5 | n/a | -0.5 | 11.5 | 33.0 | 35.7 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 38 |
Opened positions | 37 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 503.25 mm |
Total shares | 21.62 mm |
Total puts | 0.00 |
Total calls | 259.39 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Digital Transformation Sponsor | 11.39 mm | $0.00 |
Aea Growth Equity Fund | 6.65 mm | $0.00 |
Shaolin Capital Management | 765.15 k | $126.00 k |
NMR Nomura | 275.00 k | $0.00 |
D. E. Shaw & Co. | 220.65 k | $43.91 mm |
GS Goldman Sachs | 210.46 k | $34.73 mm |
Security Benefit Life Insurance | 207.31 k | $121.42 mm |
EHP Funds | 203.94 k | $33.65 mm |
Walleye Capital | 200.72 k | $33.12 mm |
Calamos Advisors | 156.25 k | $31.09 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Mar 24 | Stephen Divers | Class A Common Stock | Payment of exercise | Dispose F | No | No | 5.7 | 8,554 | 48.76 k | 57,470 |
19 Mar 24 | Stephen Divers | Class A Common Stock | Grant | Acquire A | No | No | 5.69 | 59,500 | 338.56 k | 66,024 |
5 Jan 24 | Stephen Divers | Class A Common Stock | Payment of exercise | Dispose F | No | No | 6.1 | 3,369 | 20.55 k | 6,524 |
3 Jan 24 | American Oncology Network Inc - Ordinary Shares | Class A Common Stock | Grant | Acquire A | No | No | 0 | 9,893 | 0.00 | 9,893 |